The effectual outcomes of AMPK induction in impeding tumor progression thus open a new door to advocating different combination strategies, including those duple-targeted remedies mentioned above, in the treatment of chemoresistance and carcinomatosis of ovarian cancer. The gene discussed is PRKAA1; the disease is ovarian cancer.